The Measurement and Reporting Committee (MARC) of MN Community Measurement in October approved a recommendation to align with recently released guidelines and the HEDIS Colorectal Cancer Screening measure. The proposed changes are set to begin report year 2017, for 2016 dates of service.
Dating back to 2006, MNCM has publicly reported a colorectal cancer screening measure. In 2010, MNCM converted this measure to our Direct Data Submission (DDS) process which enabled clinic level reporting. The measure continued to be adapted from the National Committee for Quality Assurance’s (NCQA’s) HEDIS Colorectal Cancer Screening measure, however, with recent changes in guidelines for colorectal screening a few technical changes were required.
In addition to the current numerator screening options (colonoscopy every 10 years, flexible sigmoidoscopy every five years, or fecal occult blood test annually), MARC recommended two additions to achieve alignment with the HEDIS Colorectal Cancer Screening measure for the 2017 report year: A) CT Colonography during the measurement year or the four years prior to the measurement year; and B) FIT-DNA test (e.g. Cologuard®) during the measurement year or the two years prior to the measurement year. Additionally, MARC recommends removal of CT Colonography as an allowable exclusion.
NCQA released their final specifications on October 3, 2016, which added the two aforementioned screening methods to the HEDIS Colorectal Cancer Screening measure and clarified that there are two types of FOBT tests: guaiac (gFOBT) and immunochemical (FIT).
For more information, contact email@example.com.